Friday, February 17, 2012 9:48:59 AM
Not sure about the extra 'D'; Could be interim while RS? Could be being late and unaudited financials...
FROM THE FINANCIALS:
"...1) The Form 10-K for the period ending March 31, 2011 was due on June 29, 2011; the Form 10-Q for the period ended June 30, 2011
was due on August 15, 2011and the Form 10-Q for the period ended September 30, 2011 was due on December 14, 2011. Due to the
pending litigation and the difficulties in receiving complete and critical information from the prior Directors and Officers who
resigned on April 15, 2011, the Form 10-K for the fiscal year ended March 31, 2011and the Form 10-Q for the periods ended June 30,
2011 and September 30, 2011 were not completed as of the original filing deadline. Due to the late filing, the Company Common
Stock trading has been moved from the Over the Counter Bulletin Board under the symbol SECI.OB to trading on the Pink Sheets
under the symbol SECI.PK. The late reports are expected to be filed on or before February 14, 2012.
2) Reverse Stock Split. The Company is in the process of restructuring its organization as well as its operations. A Definitive Schedule
14C was filed on January 9, 2012 regarding the 500-1 reverse stock split approved by the majority shareholders. The Company is
currently working with the regulatory authorities to process this request for a reverse split. The impact of this restructuring will assist
the Company in its efforts to reestablish its operations and to move forward as a going concern in 2012...."
So, are you back or just visiting?
g.p.
Recent SECI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 08:01:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/17/2024 06:28:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 08:38:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:00:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM